Sherwood and Bellview Elementary Schools students can visit Mars, create a hard hat or even grow peas without soil in their newly updated STEM labs.
Nike co-founder Phil Knight and his wife, Penny, made headlines in 2025 when they pledged $2 billion to the Oregon Health & Science University’s Knight Cancer Institute to help transform the treatment ...
Workstation Mode for Enhanced Productivity Workstation Mode on Xiaomi Pad 8 is designed to support more focused and efficient workflows. The interface transforms to support more structured ...
Greater Hazleton Area and beyond Hazleton Area School Retirees breakfast: 9:15 a.m. Wednesday, March 11. Tom’s Kitchen. Any recent or long-time retirees may join. Order from the menu. Pennsylvania ...
Dr Schwab works for GSK, a drug company. His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial intelligence (AI). He is applying this to ...
Newspoint on MSN
KMC Delhi recruitment 2026: Recruitment for 57 non-teaching posts in DU's Kirori Mal College, opportunity to apply till March 27
Kirori Mal College Recruitment 2026: Kirori Mal College, Delhi University, has announced recruitment for non-teaching positions across various departments. A total of 57 positions will be filled ...
Newspoint on MSN
JEE Advanced 2026: JEE Advanced exam on May 17, registrations open from April 23; opportunity for those with a rank of 2.50 lakh.
JEE Advanced Exam Date 2026: IIT Roorkee has announced the registration process and exam schedule for JEE Advanced 2026. This year, the exam will be conducted by IIT Roorkee. According to the ...
Because that’s what the Mapparium at the Mary Baker Eddy Library is: a three-story tall, stained-glass globe that you walk through on a bridge, and it’s one of the most mind-bending experiences you ...
The MacBook Neo is basically the M1 MacBook Air all over again. That laptop changed the game in 2020, and became the default option for just about anyone who wanted a great all-around thin-and-light ...
NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results